Pharmala Biotech Holdings Inc.
MDXXF
$0.07
$0.000.00%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.52% | -155.94% | -188.86% | -207.82% | -191.27% |
| Total Depreciation and Amortization | 158.90% | 953.19% | 49.23% | 160.87% | 440.74% |
| Total Amortization of Deferred Charges | -2.35% | -26.87% | 81.46% | 51.70% | 22.45% |
| Total Other Non-Cash Items | -26.96% | -2.03% | 201.62% | 2,738.04% | 835.16% |
| Change in Net Operating Assets | 221.22% | 143.02% | 24.23% | -652.86% | -1,005.49% |
| Cash from Operations | -56.19% | -215.83% | -108.11% | -60.28% | -76.12% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -257.93% | -286.50% | -148.52% | -169.81% | 56.64% |
| Cash from Investing | -259.40% | -287.76% | -148.52% | -169.81% | 56.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 99.55% | 98.05% | 108.13% | 984.88% | 207.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 41.21% | 41.21% | -- | -- | -- |
| Cash from Financing | 99.21% | 97.49% | 88.27% | 910.19% | 185.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -369.83% | -269.08% | -3,700.00% | 131.97% | 95.27% |